Skip to main content
Review

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review.

Syrowatka A, Song W, Amato MG, et al. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. Lancet Digit Health. 2022;4(2):e137-e148. doi: 10.1016/s2589-7500(21)00229-6

Save
Print
March 9, 2022
Syrowatka A, Song W, Amato MG, et al. Lancet Digit Health. 2022;4(2):e137-e148.

The near ubiquitous use of electronic health records has increased interest in using artificial intelligence (AI) to detect errors, including preventable adverse drug events (ADEs). This scoping review identified 78 studies of AI conducted since 1998, and identified promising areas where AI could be used to predict (e.g., therapeutic response) or detect (e.g., medication prescribing errors) patient harm. 

Save
Print
Cite
Citation

Syrowatka A, Song W, Amato MG, et al. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. Lancet Digit Health. 2022;4(2):e137-e148. doi: 10.1016/s2589-7500(21)00229-6